Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Insegia (PAS)
i
Other names:
G17DT, PAS, polyclonal antibody stimulator
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(3)
News
Trials
Company:
Cancer Advances
Drug class:
Gastrin-17 inhibitor
‹
›
Associations
(3)
News
Trials
VERI cancer hierarchy
Reset Filters
GAST expression
Gastric Cancer
GAST expression
Gastric Cancer
PAS
Sensitive: C3 – Early Trials
PAS
Sensitive
:
C3
PAS
Sensitive: C3 – Early Trials
PAS
Sensitive
:
C3
CCKBR expression
Gastric Cancer
CCKBR expression
Gastric Cancer
PAS
Sensitive: C3 – Early Trials
PAS
Sensitive
:
C3
PAS
Sensitive: C3 – Early Trials
PAS
Sensitive
:
C3
PD-L1 expression
Gastric Cancer
PD-L1 expression
Gastric Cancer
PAS
Sensitive: C3 – Early Trials
PAS
Sensitive
:
C3
PAS
Sensitive: C3 – Early Trials
PAS
Sensitive
:
C3
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.